Added 3 months ago Drug news
AMAG reports on FDA advisory committee meeting to consider status of Makena which has been approved to reduce preterm birth.
AMAG Pharmaceuticals, Inc. announced the FDA Bone, Reproductive and Urologic Drugs Advisory Committee met to better understand and interpret the...
Added 11 months ago Drug news
AMAG Pharmaceuticals announced topline results from PROLONG, a randomized, double-blinded, placebo-controlled clinical trial evaluating Makena (progestin) in patients with a...
Added 1 year ago Drug news
Qiagen announced the U.S. regulatory approval of PartoSure, which is a novel test for assessing the risk of spontaneous preterm...
An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.
Biosimilars are uniquely placed to change clinical practice in the fields of gastroenterology, rheumatology, and dermatology. The adoption of biosimilars can improve patient access to the most appropriate treatment, at the optimum time, to ensure the best possible long-term disease outcomes.
See information on best practice in solid organ transplantation, and expert discussions on related hot topics.
The Atopic Dermatitis Knowledge Centre is an educational resource, intended for healthcare professionals, that provides credible medical information on the epidemiology, pathophysiology and burden of atopic dermatitis, as well as diagnostic techniques, treatment regimens and guideline recommendations.
Anticoagulation therapy for Stroke Prevention Learning Zone offers a deep-dive into atrial fibrillation causes, consequences, diagnosis and management to help you deliver optimal care and prevent strokes in patients living with this common arrhythmia.
This guideline covers the care of women at increased risk of or with symptoms and signs of preterm labour (before 37 weeks) and women having a planned preterm birth.
Added 4 years ago
Objective: The aim of the present study was to understand the role played by Atosiban, an oxytocin receptor antagonist, on...
Added 4 years ago